Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B-Reference-Cited by-同舟云学术

Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B

Published:2018-09 Issue:3 Volume:69 Page:584-593
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Rinker Franziska,Zimmer Christine L.,Höner zu Siederdissen Christoph,Manns Michael P.,Kraft Anke R.M.,Wedemeyer Heiner,Björkström Niklas K.,Cornberg Markus

Funder

German Center for Infection Research

Swedish Research Council

Swedish Cancer Society

Swedish Foundation for Strategic Research

Swedish Society for Medical Research

Cancer Research Foundations of Radiumhemmet

Knut and Alice Wallenberg Foundation

Novo Nordisk Foundation

Åke Wiberg’s Foundation

Center for Innovative Medicine

Stockholm County Council

Karolinska Institutet

Publisher

Elsevier BV

Subject

Hepatology

Reference29 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

2. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection;J Hepatol,2017

3. Systematic review: cessation of long-term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen-negative chronic hepatitis B;Chang;Aliment Pharmacol Ther,2015

4. Discontinuation of oral antivirals in chronic hepatitis B: a systematic review;Papatheodoridis;Hepatology,2016

5. Viral and host responses after stopping long-term nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B;Honer Zu Siederdissen;J Infect Dis,2016

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing HBV-specific T cell responses through a combination of epigenetic modulation and immune checkpoint inhibition;2024-09-08

2. Effect of nucleos(t)ide analogue discontinuation on the prognosis of HBeAg‐negative hepatitis B virus‐related hepatocellular carcinoma after hepatectomy: A propensity score matching analysis;Cancer Medicine;2024-08

3. Higher hepatitis B core-specific T cell response is associated with a lower risk of clinical relapse after discontinuation of oral antiviral treatment;Journal of Microbiology, Immunology and Infection;2024-08

4. Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study);Journal of Hepatology;2024-08

5. PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trial;Journal of Hepatology;2024-07